On November 28, 2016, the 21th participant out of 23 completed their 12-month follow-up interview in our Phase 2 study of MDMA-assisted psychotherapy in 23 subjects with chronic PTSD in Boulder, Colorado, …
On November 10 and November 28, 2016, the fifth and sixth of 10 participants completed their 12-month follow-up interviews in ourIsraeli Phase 2 study of MDMA-assisted psychotherapy for PTSD. Led by Principal …
On November 27, 2016, investigators gathered for the formal closeout of our Phase 2 pilot study of MDMA-assisted psychotherapy for PTSD in Vancouver, Canada. Conducted by Clinical Trial Leader Alli Feduccia, …
On October 17, 2016, the sixth and final participant completed their 12-month follow-up interview in our Phase 2 pilot study of MDMA-assisted psychotherapy for PTSD in Vancouver, Canada. All participants …
On October 21, 2016, the fourth of 10 participants completed their 12-month follow-up interview in our Israeli Phase 2 study of MDMA-assisted psychotherapy for PTSD. Led by Principal Investigator Moshe …
On October 17, 2016, the 20th participant out of 23 completed their 12-month follow-up interview in our Phase 2 study of MDMA-assisted psychotherapy in 23 subjects with chronic, treatment-resistant PTSD …
On October 3, 2016, the 19th participant completed their long-term (12-month) follow-up interview in our Phase 2 study of MDMA-assisted psychotherapy for 23 subjects with chronic, treatment-resistant PTSD …
WASHINGTON, D.C. — Today, the Drug Enforcement Administration (DEA) announced their intention to grant licenses to additional marijuana growers for research, thereby ending the DEA-imposed 48-year monopoly …
On March 24, 2016, the final open label experimental treatment session was completed in our Israeli Phase 2 study of MDMA-assisted psychotherapy for PTSD. In addition to being the final experimental …
On January 21 and February 26, 2016, the 17th and 18th participants completed their 12-month long-term follow-up interviews in our Phase 2 study of MDMA-assisted psychotherapy for 23 subjects with chronic, …
On February 5, 2016, the 23rd and final participant had their two-month follow-up evaluation in our Phase 2 study of MDMA-assisted psychotherapy for 23 subjects with chronic, treatment-resistant PTSD in …
On January 31, 2016, the tenth and final subject received their last blinded experimental treatment session in our Israeli Phase 2 study of MDMA-assisted psychotherapy for PTSD. In addition to being the …
